Concomitant RAS and BRAF V600E Mutations in Unresectable Metastatic CRC: A Case of Long-term Survival [0.03%]
RAS和BRAF V600E突变并发的不可切除性转移性结直肠癌一例长期存活报告
Kazuo Kitagawa,Naoto Takahashi,Mizuki Fukuda et al.
Kazuo Kitagawa et al.
Detection of rat sarcoma virus (RAS) and B rapidly accelerated fibrosarcoma (BRAF) mutations is critical for selecting an appropriate treatment for metastatic colorectal cancer (mCRC). Although RAS and BRAF V600E mutations are traditionally...
Pathological Response of Locally Recurrent Rectal Cancer to Neoadjuvant Chemoradiotherapy [0.03%]
局部复发性直肠癌对新辅助放化疗的病理反应
Yuichiro Yokoyama,Kosuke Ozaki,Hiroaki Nozawa et al.
Yuichiro Yokoyama et al.
Objectives: The primary objective was to elucidate the apoptotic response of locally recurrent rectal cancer (LRRC) to neoadjuvant chemoradiotherapy (CRT) using M30 CytoDeath immunostaining. Secondary objectives were to e...
Intracorporeal Anastomosis for Robotic-assisted Right Hemicolectomy Using an Umbilical Assistant Port [0.03%]
经脐辅助孔机器人右半结肠切除术中端端吻合的应用
Yusuke Kitagawa,Hisanori Miki,Takumi Yamamoto et al.
Yusuke Kitagawa et al.
There is ongoing debate on the respective merits of extracorporeal and intracorporeal anastomoses in patients undergoing minimally invasive surgery for right-sided colon cancer. Herein, we report the benefits of intracorporeal anastomosis f...
Novel Preoperative Cancer-Specific Glasgow Prognostic Score Strongly Predicts Survival in Stage II/III Colorectal Cancer [0.03%]
新的术前癌症特异性格拉斯哥预后评分可预测II/III期结直肠癌患者的生存率
Teppei Kamada,Yasuhiro Takano,Keisuke Goto et al.
Teppei Kamada et al.
Objectives: The Glasgow Prognostic Score (GPS), derived from serum C-reactive protein (CRP) and albumin (Alb) levels, is a validated prognostic marker in colorectal cancer (CRC). However, it lacks tumor-specific component...
Propensity Score-matched Analysis of the Impact of Direct-acting Oral Anticoagulants on Fecal Immunochemical Test Performance [0.03%]
直接口服抗凝血药物对粪便免疫化学法检测性能影响的倾向性评分匹配分析
Yasuhiko Hamada,Akina Shigefuku,Hiroto Suzuki et al.
Yasuhiko Hamada et al.
Objectives: The fecal immunochemical test (FIT) is widely used for colorectal cancer (CRC) screening, owing to its high diagnostic accuracy. Antithrombotic medications, particularly direct-acting oral anticoagulants (DOAC...
Robot Assisted Low Anterior Resection for Obese Rectal Cancer Patients: A Single-center Analysis of Short-term Outcomes [0.03%]
机器人辅助低位前切术治疗肥胖型直肠癌患者的短期疗效分析
Fuminori Teraishi,Yusuke Yoshida,Ryohei Shoji et al.
Fuminori Teraishi et al.
Objectives: This study evaluates the short-term safety and technical feasibility of robot-assisted low anterior resection (RALAR) for rectal cancer in obese patients (BMI ≥ 25 kg/m2) compared to non-obese patients. ...
Robotic Right Hemicolectomy for Cecal Cancer with a Rare Ileocolic Artery-Middle Colic Artery Common Trunk: A Case Report [0.03%]
罕见回结肠动脉与中结肠动脉共干型盲部癌的机器人右半结肠切除术一例报告
Junko Mukohyama,Kenji Ino,Satoko Monma et al.
Junko Mukohyama et al.
While venous anomalies of the right colon are relatively common, arterial variations are rare. We report a case of cecal cancer with a unique vascular anomaly. A 65-year-old man presented with fatigue and melena. Colonoscopy revealed a ceca...
Characteristics and Surgical Outcomes of Patients with Intestinal Endometriosis Undergoing Bowel Resection [0.03%]
肠道切除术治疗肠腔内子宫内膜异位症患者的临床特征和手术结局分析
Hisashi Ro,Yutaka Kojima,Makoto Takahashi et al.
Hisashi Ro et al.
Objective: To retrospectively evaluate the clinical features, perioperative findings, and long-term outcomes of patients who underwent bowel resection for intestinal endometriosis, and to clarify diagnostic and therapeuti...
Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2024 for the Clinical Practice of Inflammatory Bowel Disease-Associated Intestinal Neoplasia (English Version) [0.03%]
日本大肠癌学会(JSCCR)2024年炎症性肠病相关肠肿瘤临床实践指南(英文版)
Soichiro Ishihara,Shinji Tanaka,Toshio Uraoka et al.
Soichiro Ishihara et al.
The number of patients with inflammatory bowel disease (IBD), including ulcerative colitis (UC) and Crohn's disease (CD), continues to increase in many countries and regions. With recent rapid advances in medical therapies targeting intesti...
The Japan Society of Coloproctology Practice Guidelines for Fecal Incontinence 2024 (Revised Second Edition) [0.03%]
2024年日本大肠肛门病学会粪失禁实践指南（修订第二版）
Keiji Koda,Toshiki Mimura,Tetsuo Yamana et al.
Keiji Koda et al.
In 2024, the second edition of the Japan Society of Coloproctology (JSCP) Practice Guidelines for Fecal Incontinence was published in Japan, followed by the release of this English version. This marks the first major revision in 7 years sin...